Related Experiment Video
Updated: Jun 12, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes
Jun-Xu Gu1, Juan Huang2, Kun Wang3
1Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
Insights
Elevated lipoprotein(a) [Lp(a)] levels are linked to increased coronary heart disease (CHD) severity and predict major adverse cardiovascular events (MACEs) in type 2 diabetes mellitus (T2DM) patients. This finding highlights Lp(a) as a significant risk factor for cardiovascular complications in this population.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Clinical Research
Background:
- High lipoprotein(a) [Lp(a)] concentration is associated with atherosclerosis.
- The predictive value of Lp(a) for coronary heart disease (CHD) extent and major adverse cardiovascular events (MACEs) in diabetic patients is not fully understood.
Purpose of the Study:
- To investigate if elevated Lp(a) exacerbates CHD in type 2 diabetes mellitus (T2DM) patients.
- To assess the predictive utility of Lp(a) for MACEs in T2DM patients.
Main Methods:
- Included 4332 T2DM patients who underwent coronary angiography (CAG).
- Correlated Lp(a) levels with CHD severity using correlation analysis.
- Evaluated MACEs using Cox regression analysis over a 7-year follow-up.
Main Results:
- Lp(a) concentrations were significantly higher in the CHD group and correlated positively with disease severity.
- Elevated Lp(a) is a risk factor for CHD occurrence (OR=1.597), vessel involvement (OR=1.908), and Gensini Score (OR=2.002).
- Increased Lp(a) levels were independently associated with MACEs (HR=1.915).
Conclusions:
- Confirmed a positive correlation between Lp(a) levels, CHD lesion count, and Gensini scores.
- Lp(a) levels predict MACEs in T2DM patients, underscoring its clinical significance.
Background:
High circulatory lipoprotein(a) [Lp(a)] concentration promotes atherosclerosis; however, its efficacy in predicting the extent of atherosclerotic coronary heart disease (CHD) with coronary artery obstruction and major adverse cardiovascular events (MACEs) in diabetic patients remains questionable. This study aimed to examine whether elevated circulating Lp(a) levels exacerbate CHD and to assess their utility in predicting MACEs in individuals diagnosed with type 2 diabetes mellitus (T2DM).
Methods:
In total, 4332 patients diagnosed with T2DM who underwent coronary angiography (CAG) were included and categorized into two groups (CHD and non-CHD) based on the CAG results. We used a correlation analysis to explore the potential links between the levels of circulating Lp(a) and CHD severity. Cox regression analysis was performed to evaluate MACEs.
Results:
The concentrations of circulating Lp(a) were markedly elevated in the CHD group and positively correlated with disease severity. Our results indicate that elevated circulating Lp(a) is a crucial risk factor that significantly contributes to both the progression and severity of CHD. The differences between the two groups are evident in the risk of CHD occurrence [odds ratio (OR) = 1.597, 95 % confidence interval (CI): 1.354-1.893, p < 0.001], the different levels of vessel involvement (OR = 1.908 for triple-vessel vs. single-vessel disease, 95 % CI: 1.401-2.711, p < 0.001), and their relation to the Gensini Score (OR = 2.002 for high vs. low GS, 95 % CI: 1.514-2.881, p < 0.001). Over the course of the 7-year follow-up period, the multivariate Cox regression analysis indicated that increased levels Lp(a) levels are independently associated with the occurrence of MACEs [hazard ratio (HR) = 1.915, 95 % CI: 1.571-2.493, p < 0.001].
Conclusion:
We confirmed a positive correlation among circulating Lp(a) levels, CHD lesions count, and Gensini scores. Moreover, Lp(a) levels have predictive significance for the occurrence of MACEs in T2DM patients.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Diabetes Mellitus: Type 2 and Gestational
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Diabetes: Symptoms, Diagnosis, and Complications

